Perkins Coie Trust CO Gilead Sciences, Inc. Transaction History

Perkins Coie Trust CO

$416 Million
Q2 2024

A detailed history of Perkins Coie Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Perkins Coie Trust CO holds 3,780 shares of GILD stock, worth $313,059. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,780

Previous 3,780 -0.0%

Holding current value

$313,059

Previous $276,000 6.16%

% of portfolio

0.06%

Previous 0.07%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$71.58 - $87.29 $1,789 - $2,182	-25 Reduced 0.66%	3,780 $276,000
Q4 2023 Jan 09, 2024	SELL	$73.27 - $83.09 $4,542 - $5,151	-62 Reduced 1.6%	3,805 $308,000
Q3 2023 Oct 11, 2023	BUY	$73.94 - $80.67 $282,450 - $308,159	3,820 Added 8127.66%	3,867 $289,000
Q2 2023 Jul 13, 2023	SELL	$76.01 - $86.7 $2,584 - $2,947	-34 Reduced 41.98%	47 $3,000
Q4 2020 Jan 12, 2021	SELL	$56.65 - $64.55 $2,662 - $3,033	-47 Reduced 36.72%	81 $5,000
Q3 2020 Oct 13, 2020	SELL	$62.1 - $78.08 $9,439 - $11,868	-152 Reduced 54.29%	128 $8,000
Q1 2020 Apr 10, 2020	SELL	$62.63 - $80.22 $3,757 - $4,813	-60 Reduced 17.65%	280 $21,000
Q4 2019 Jan 09, 2020	SELL	$61.62 - $67.78 $12,324 - $13,556	-200 Reduced 37.04%	340 $22,000
Q1 2018 Apr 16, 2018	SELL	$72.84 - $88.8 $1,165 - $1,420	-16 Reduced 2.88%	540 $41,000
Q4 2017 Jan 12, 2018	SELL	$71.15 - $83.52 $10,103 - $11,859	-142 Reduced 20.34%	556 $40,000
Q3 2017 Oct 13, 2017	BUY	$72.11 - $85.47 $50,332 - $59,658	698	698 $57,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $104B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Coie Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Coie Trust CO with notifications on news.

Account

Perkins Coie Trust CO Gilead Sciences, Inc. Transaction History